SLS
SELLAS Life Sciences GroupDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
SLS vs peer average
33/100
SLS vs. peer average (D vs. C)
Grade spread
B 5 · C 3 · D 2 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
FULC is the first available peer comparator.
Small-cap clinical-stage biotech with valuation driven by pipeline progress rather than commercial revenue; useful for comparing binary data-readout and financing sensitivity.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SLS
SELLAS Life Sciences Group
FULC
Fulcrum Therapeutics
Grade
D
F
Momentum
100
2
Value
41
57
Sentiment
0
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs FULC
SLS / FULC
Grade Position
Below peers
SLS vs. peer average (D vs. C)
33/100
Momentum
100
SLSValue
41
FULCSentiment
0
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SLS
FULC is the first peer returned for this comparison set.